p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours

Rooshdiya Z. Karim, Sebastien K. Gerega, Yeehwa Yang, Andrew Spillane, Hugh Carmalt, Richard A. Scolyer, Cheok Soon Lee

    Research output: Contribution to journalArticle

    30 Citations (Scopus)

    Abstract

    Aims: Control of cell cycling and proliferation is critical to the development of neoplasia and may play a role in the pathogenesis of phyllodes tumours (PTs). This study aimed to evaluate the immunohistochemical expression of certain proteins from the G1 ⁄ S transition of the cell cycle in a cohort of PTs, to determine their role in tumour pathogenesis and to identify any associations with patient outcome. Methods and results: Sixty-five PTs (34 benign, 23 borderline and eight malignant) diagnosed at a single institution between 1990 and 2006 were analysed. Immunohistochemistry for p16, pRb, cyclin D1 and Ki67 was performed. Expression of the following markers increased significantly with tumour grade: stromal nuclear and cytoplasmic p16 (P = 0.01 and 0.002, respectively), stromal and epithelial pRb (P = 0.000 000 06 and 0.004, respectively), and stromal and epithelial Ki67 (P = 0.03 and 0.04, respectively). Epithelial pRb scores of 7 (range 0–7) were significantly associated with reduced disease-free survival (DFS) compared with scores of <7 (P = 0.0009). No relationship was found between cyclin D1 expression in either the epithelium or the stroma, and grade or DFS. Conclusions: The results suggest that alterations at the G1 ⁄ S transition of the cell cycle play an important role in the progression of PTs.
    Original languageEnglish
    Pages (from-to)868-875
    Number of pages8
    JournalHistopathology
    Volume56
    Issue number7
    DOIs
    Publication statusPublished - 2010

    Keywords

    • immunohistochemistry
    • tumors

    Cite this